🚀

GSK GlaxoSmithKline PLC ADR

Health Care > Pharmaceuticals, Biotechnology & Life Sciences > Pharmaceuticals > Pharmaceuticals  | NYSE, LargeCap |  Last Price: 59.13 | 2026-02-27 | Atrp: 1.92

Sat 21 Feb 2026 to Fri 27 Feb 2026: Score 4

MetricPreviousNewChangeInterpretation
✅Short Ratio3.641.97▼ -45.88%Bullish. Lower is better. Significant improvement
✅Short Percent0.88%0.65%▼ -26.14%Bullish. Lower is better. Significant decrease; still high, potential for squeeze if positive catalysts emerge
Percentage of shares sold short
✅Price Sales TTM3.65613.5671▼ -2.43%Bullish. Lower is better. Lower multiple; market willing to pay less per dollar of sales
Stock price divided by revenue per share over the trailing twelve months
❌Forward PE22.675723.4192▲ 3.28%Bearish. Lower is better. Slight decline
Stock price divided by expected future earnings
❌PEG Ratio0.38190.4986▲ 30.56%Bearish. Lower is better. Significant increase, worsening the value relative to growth
P/E ratio adjusted for growth rate

Sat 07 Feb 2026 to Sat 14 Feb 2026: Score 3

MetricPreviousNewChangeInterpretation
✅Short Ratio4.973.64▼ -26.76%Bullish. Lower is better. Significant improvement
✅Wall Street Target Price53.220556.0584▲ 5.33%Bullish. Higher is better. Higher analyst expectations, pointing to increased optimism for future performance
Analysts' consensus target price for the stock
✅Price Sales TTM3.69983.6199▼ -2.16%Bullish. Lower is better. Lower multiple; market willing to pay less per dollar of sales
Stock price divided by revenue per share over the trailing twelve months
✅Price Book MRQ5.40935.3005▼ -2.01%Bullish. Lower is better. Closer to 1; less overvalued on assets but improved perception
Stock price divided by book value per share for the most recent quarter
✅Enterprise Value/Revenue3.13853.098▼ -1.29%Bullish. Lower is better. Slight improvement
Enterprise value divided by revenue
✅Enterprise Value/EBITDA8.63018.5187▼ -1.29%Bullish. Lower is better. Slight improvement
Enterprise value to earnings before interest, taxes, depreciation
❌EPS Estimate Current Year4.81484.7391▼ -1.57%Bearish. Higher is better. Slight decrease; reduced outlook for current year earnings
Expected earnings per share this year
❌Short Percent0.87%0.88%▲ 1.15%Bearish. Lower is better. Slight increase; still high, potential for squeeze if positive catalysts emerge
Percentage of shares sold short
❌Forward PE11.350722.6757▲ 99.77%Bearish. Lower is better. Substantial decline
Stock price divided by expected future earnings

Fri 30 Jan 2026 to Sat 07 Feb 2026: Score 10

MetricPreviousNewChangeInterpretation
✅Quarterly Earnings Growth YOY231%551%▲ 137.5%Bullish. Higher is better. Quarterly earnings growth YOY growth accelerating.
Year-over-year growth in quarterly earnings
✅EBITDA$9519M$13210M▲ 38.78%Bullish. Higher is better. Increase in earnings before interest, taxes, depreciation, and amortization; indicates stronger operational cash flow
Earnings before interest, taxes, depreciation, and amortization
✅Return On Assets TTM7.13%9.78%▲ 37.17%Bullish. Higher is better. Return on assets TTM growth accelerating.
Efficiency in generating profits from total assets
✅Enterprise Value$123.25B$138.62B▲ 12.47%Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments
Market capitalization plus debt minus cash
✅PEG Ratio0.4230.3819▼ -9.72%Bullish. Lower is better. Slight decrease, improving the value relative to growth
P/E ratio adjusted for growth rate
✅EPS Estimate Current Year4.50234.8148▲ 6.94%Bullish. Higher is better. Slight increase; improved outlook for current year earnings
Expected earnings per share this year
✅EPS Estimate Next Year4.81825.1506▲ 6.9%Bullish. Higher is better. Slight raised expectations for further out
Expected earnings per share next year
✅Return On Equity TTM41.52%43.31%▲ 4.31%Bullish. Higher is better. Return on equity TTM growth accelerating.
Efficiency in generating profits from shareholders' equity
✅Wall Street Target Price52.351153.2205▲ 1.66%Bullish. Higher is better. Higher analyst expectations, pointing to increased optimism for future performance
Analysts' consensus target price for the stock
✅Earnings Per Share3.683.79▲ 2.99%Bullish. Higher is better. Slight increase in earnings per share
Profit allocated to each outstanding share
✅Profit Margin17.08%17.5%▲ 2.46%Bullish. Higher is better. Profit margin growth accelerating.
Percentage of revenue that turns into profit
✅Gross Profit TTM$23299M$23720M▲ 1.81%Bullish. Higher is better. Slight increase, but margins may be improving
Revenue minus cost of goods sold over the trailing twelve months
✅Revenue TTM$32166M$32667M▲ 1.56%Bullish. Higher is better. Slight top-line expansion
Total revenue over the trailing twelve months
✅Revenue Per Share TTM15.8216.128▲ 1.95%Bullish. Higher is better. Slight improvement
Revenue generated per outstanding share over the trailing twelve months
❌Quarterly Revenue Growth YOY71%61%▼ -7.46%Bearish. Higher is better. Quarterly revenue growth YOY growth slowing.
Year-over-year growth in quarterly revenue
❌Enterprise Value/EBITDA8.25298.6301▲ 4.57%Bearish. Lower is better. Slight decline
Enterprise value to earnings before interest, taxes, depreciation
❌Forward PE9.514711.3507▲ 19.3%Bearish. Lower is better. Moderate decline
Stock price divided by expected future earnings
❌Price Sales TTM3.21643.6998▲ 15.03%Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales
Stock price divided by revenue per share over the trailing twelve months
❌Price Book MRQ4.57785.4093▲ 18.16%Bearish. Lower is better. Further to 1; more overvalued on assets but worsened perception
Stock price divided by book value per share for the most recent quarter
❌Enterprise Value/Revenue2.77173.1385▲ 13.23%Bearish. Lower is better. Moderate decline
Enterprise value divided by revenue
❌Operating Margin TTM32.61%16.67%▼ -48.88%Bearish. Higher is better. Operating margin TTM growth slowing.
Percentage of revenue left after operating expenses

Fri 23 Jan 2026 to Fri 30 Jan 2026: Score -8

MetricPreviousNewChangeInterpretation
❌Short Percent0.74%0.87%▲ 17.57%Bearish. Lower is better. Moderate increase; still high, potential for squeeze if positive catalysts emerge
Percentage of shares sold short
❌Price Sales TTM3.05683.2164▲ 5.22%Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales
Stock price divided by revenue per share over the trailing twelve months
❌Short Ratio4.774.97▲ 4.19%Bearish. Lower is better. Slight decline
❌PEG Ratio0.41850.423▲ 1.08%Bearish. Lower is better. Slight increase, worsening the value relative to growth
P/E ratio adjusted for growth rate
❌Forward PE9.41629.5147▲ 1.05%Bearish. Lower is better. Slight decline
Stock price divided by expected future earnings
❌Price Book MRQ4.5294.5778▲ 1.08%Bearish. Lower is better. Further to 1; more overvalued on assets but worsened perception
Stock price divided by book value per share for the most recent quarter
❌Enterprise Value/Revenue2.69092.7717▲ 3%Bearish. Lower is better. Slight decline
Enterprise value divided by revenue
❌Enterprise Value/EBITDA8.0128.2529▲ 3.01%Bearish. Lower is better. Slight decline
Enterprise value to earnings before interest, taxes, depreciation
✅Book Value5.38185.5446▲ 3.03%Bullish. Higher is better. Slight increase; stock now trades closer to book value
Net asset value of the company per share
✅Earnings Per Share3.573.68▲ 3.08%Bullish. Higher is better. Slight increase in earnings per share
Profit allocated to each outstanding share
✅Enterprise Value$116.32B$123.25B▲ 5.95%Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments
Market capitalization plus debt minus cash

Wed 14 Jan 2026 to Fri 23 Jan 2026: Score 9

MetricPreviousNewChangeInterpretation
✅Wall Street Target Price49.970351.9761▲ 4.01%Bullish. Higher is better. Higher analyst expectations, pointing to increased optimism for future performance
Analysts' consensus target price for the stock
✅PEG Ratio0.42770.4185▼ -2.15%Bullish. Lower is better. Slight decrease, improving the value relative to growth
P/E ratio adjusted for growth rate
✅EPS Estimate Current Year4.36234.5023▲ 3.21%Bullish. Higher is better. Slight increase; improved outlook for current year earnings
Expected earnings per share this year
✅EPS Estimate Next Year4.74694.8182▲ 1.5%Bullish. Higher is better. Slight raised expectations for further out
Expected earnings per share next year
✅Forward PE9.62469.4162▼ -2.17%Bullish. Lower is better. Slight improvement
Stock price divided by expected future earnings
✅Price Sales TTM3.13533.0568▼ -2.5%Bullish. Lower is better. Lower multiple; market willing to pay less per dollar of sales
Stock price divided by revenue per share over the trailing twelve months
✅Price Book MRQ4.62944.529▼ -2.17%Bullish. Lower is better. Closer to 1; less overvalued on assets but improved perception
Stock price divided by book value per share for the most recent quarter
✅Enterprise Value/Revenue2.77932.6909▼ -3.18%Bullish. Lower is better. Slight improvement
Enterprise value divided by revenue
✅Enterprise Value/EBITDA8.27538.012▼ -3.18%Bullish. Lower is better. Slight improvement
Enterprise value to earnings before interest, taxes, depreciation
❌Enterprise Value$120.37B$116.32B▼ -3.36%Bearish. Higher is better. Decreased, reflecting lower market cap and possibly debt adjustments
Market capitalization plus debt minus cash

Tue 06 Jan 2026 to Wed 14 Jan 2026: Score -8

MetricPreviousNewChangeInterpretation
❌Short Ratio2.674.77▲ 78.65%Bearish. Lower is better. Substantial decline
❌Short Percent0.56%0.74%▲ 32.14%Bearish. Lower is better. Significant increase; still high, potential for squeeze if positive catalysts emerge
Percentage of shares sold short
❌Price Sales TTM3.08433.1353▲ 1.65%Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales
Stock price divided by revenue per share over the trailing twelve months
❌Enterprise Value/Revenue2.7462.7793▲ 1.21%Bearish. Lower is better. Slight decline
Enterprise value divided by revenue
❌Enterprise Value/EBITDA8.17638.2753▲ 1.21%Bearish. Lower is better. Slight decline
Enterprise value to earnings before interest, taxes, depreciation
✅Wall Street Target Price49.345349.9703▲ 1.27%Bullish. Higher is better. Higher analyst expectations, pointing to increased optimism for future performance
Analysts' consensus target price for the stock
✅EPS Estimate Current Year4.27574.3623▲ 2.03%Bullish. Higher is better. Slight increase; improved outlook for current year earnings
Expected earnings per share this year
✅EPS Estimate Next Year4.6584.7469▲ 1.91%Bullish. Higher is better. Slight raised expectations for further out
Expected earnings per share next year
✅Enterprise Value$119B$120.37B▲ 1.15%Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments
Market capitalization plus debt minus cash

Sun 21 Dec 2025 to Tue 06 Jan 2026: Score -7

MetricPreviousNewChangeInterpretation
❌Short Ratio22.67▲ 33.5%Bearish. Lower is better. Significant decline
❌PEG Ratio0.41920.4254▲ 1.48%Bearish. Lower is better. Slight increase, worsening the value relative to growth
P/E ratio adjusted for growth rate
❌Forward PE9.4349.5694▲ 1.44%Bearish. Lower is better. Slight decline
Stock price divided by expected future earnings
❌Price Book MRQ4.5374.6038▲ 1.47%Bearish. Lower is better. Further to 1; more overvalued on assets but worsened perception
Stock price divided by book value per share for the most recent quarter
❌Short Percent0.54%0.56%▲ 3.7%Bearish. Lower is better. Slight increase; still high, potential for squeeze if positive catalysts emerge
Percentage of shares sold short
✅Enterprise Value$117.71B$119B▲ 1.09%Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments
Market capitalization plus debt minus cash